Navigation Links
Titanium Microforceps: Side-gripping

ProductsTitanium Microforceps: Side-gripping
Company Dutch Ophthalmic, USA
Item Titanium Microforceps: Side-gripping
Features 
Description Blunt tipped forceps with small, slightly rounded tips angled perpendicular to the shaft. For grasping peripheral membranes.
Info Dutch Ophthalmic, USACall Dutch Ophthalmic, USA to buy products (US and Canada only; other locations use number below) USACanada1-866-859-5660

Customer Service: (800) 75-DUTCH
Web site: http://www.dorc.nl/

Related medicine products :

1. Hydroview Insertion Forceps - Titanium
2. Titanium Bayonet Forceps
3. Titanium Foot Activated Forceps
4. Craniofix Titanium Clamp
5. Craniofix Titanium Burr Hole Clamp
6. Lorenz 1.0 mm Titanium System
7. Lorenz 2.0 mm Flexible Titanium
8. Lorenz 1.5 mm Titanium System
9. Lorenz 2.0 mm Low Profile Titanium
10. Lorenz 2.0 mm Mini-plate Titanium
11. Anteater Titanium Microdiscectomy System
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
Medicine Products:
(Date:11/30/2009)...NESVILLE, Fla., Nov. 30 The launch...he availability of the first FDA-cleared, fully-au... analysis by a radiologist of suspicious breast le...d at the Radiological Society of North America 200...rtnership with leading experts in breast MRI, ONCA...
(Date:11/30/2009)... two years of development and extensive discussion...ality and Efficiency in Health Care (IQWiG) presen... cost and benefit. The Institute can now apply the...rded by the Federal Joint Committee (G-BA). The me... recommendations to the GKV-Spitzenverband [Nation...
(Date:11/30/2009)... Keynote speaker & Author Dr. Templ... Corpus Christi, TX (Vocus) Novem...ference is set to be held in Corpus Christi from ... 2009 at the American Bank Center., , , , ,The co...d to make a nearly $300,000 economic impact on the...
(Date:11/30/2009)...al skills improve with specially designed program,...Day News) -- A special, intensive early interventi...oosting IQ along with children,s language and soci...his fashion, many children are able to learn and m...ead author of the study, published online Nov. 30 ...
(Date:11/30/2009)..., NEW YORK, Nov. 30 Reportlinker...s available in its catalogue: ,, The Future of...es and targeted opportunities for older consumers ...uture-of-Senior-Nutrition-Key-ingredients-strategi...umers.html ,, Seniors, have emerged as a power...
Breaking Medicine News(10 mins):Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3Health News:IQWiG presents a method for evaluating the relation between cost and benefit 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 3Health News:IQWiG presents a method for evaluating the relation between cost and benefit 4Health News:IQWiG presents a method for evaluating the relation between cost and benefit 5Health News:18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact 2Health News:Working Intensely Early on May Help Autistic Kids 2Health News:Working Intensely Early on May Help Autistic Kids 3Health News:Working Intensely Early on May Help Autistic Kids 4Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 2Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 3Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 4Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 5Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 6Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 7Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 8
...ormal-weight women who carry out lots of vigorous ...lop breast cancer than those who don,t exercise vi...tmenopausal American women, reported in BioMed Cen...re not overweight. , While an Investigator at the...
...oved laboratory efficiencies and standardization t... care, PLEASANTON, Calif., Oct. 30 Roche Mol...ood & Drug Administration (FDA) has approved,the C...he amount of Hepatitis C RNA in a patient,s blood....
...LOUIS, Oct. 30 Schering-Plough,Corporation (NYSE:...the,decision reached by a jury in Missouri related...f certain products sold by Warrick,Pharmaceuticals...ble laws and regulations governing reimbursement r...
...ing Pediatricians Refute MD Who Signed Prop 8 Ball...on Prop 8 campaign,today released a statement sign...ns announcing their joint opposition to Prop 8 and...sue., The pediatrician statement took issue with ...
...OLUMBIA, Mo. Long after a conflict, landmines rem...nd detonate them. According to the United Nations ...ried in 68 countries around the world. The UN est...he accuracy of a landmine radar system while minim...
...TANFORD, Calif. Investigators combing the genome ...le for triggering early-onset diabetes ,may be loo...ord ,University School of Medicine suggests. , Ea...lls in a person,s pancreas. , What triggers that ...
Other Medicine News:Health News:Vigorous activity protects against breast cancer 2Health News:Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform 2Health News:Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform 3Health News:Schering-Plough to Appeal Jury Decision in Missouri Reimbursement Case 2Health News:NO on Prop 8 Campaign Releases Statement by 300 California Pediatricians 2Health News:Engineer creating more sensitive, safer landmine detectors 2Health News:Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows 2Health News:Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows 3Health News:Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows 4
(Date:11/30/2009)...v. 30 The U.S. Food and ...74; (duloxetine HCl) for the maintenance treatment...Eli Lilly and Company (NYSE: LLY ) announced tod...be a chronic illness, it is important that doctors...s effective in both the acute and maintenance phas...
(Date:11/30/2009)...ewswire/ -- Stemline Therapeutics, Inc., a private...ing developer of oncology compounds directed to ca...ty of Texas M.D. Anderson Cancer Center (Houston, ...aboration. As part of this collaboration, M.D. And...ial of SL-401 in patients with acute myeloid leuke...
(Date:11/30/2009)... Nov. 30 Amgen Inc. (Nas...updated long-term safety and efficacy data for Npl...diopathic) thrombocytopenic purpura (ITP). Additio...n a pediatric setting as well as in patients with ...an Society of Hematology (ASH) Annual Meeting and ...
Breaking Medicine Technology:FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of M.D. Anderson Cancer Center 2Amgen Highlights Data to be Presented at ASH 2Amgen Highlights Data to be Presented at ASH 3Amgen Highlights Data to be Presented at ASH 4Amgen Highlights Data to be Presented at ASH 5Amgen Highlights Data to be Presented at ASH 6Amgen Highlights Data to be Presented at ASH 7Amgen Highlights Data to be Presented at ASH 8Amgen Highlights Data to be Presented at ASH 9Amgen Highlights Data to be Presented at ASH 10Amgen Highlights Data to be Presented at ASH 11SCOLR Pharma Inc Reports Second Quarter 2009 Financial Results 13451 1SCOLR Pharma Inc Reports Second Quarter 2009 Financial Results 13451 2SCOLR Pharma Inc Reports Second Quarter 2009 Financial Results 13451 3SCOLR Pharma Inc Reports Second Quarter 2009 Financial Results 13451 4SCOLR Pharma Inc Reports Second Quarter 2009 Financial Results 13451 5SCOLR Pharma Inc Reports Second Quarter 2009 Financial Results 13451 6SCOLR Pharma Inc Reports Second Quarter 2009 Financial Results 13451 7SCOLR Pharma Inc Reports Second Quarter 2009 Financial Results 13451 8More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 1More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 2More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 3More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 4More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 5Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 1Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 2Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 4Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 5Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 6Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 7